The complex network governing coupregulation of Oct4, Sox2, and Nanog is also noted in many human CSCs derived from renal cell carcinoma [62], hepatocellular carcinoma [63], breast cancer [64], and lung cancer [26]. This evidence concerns the gene NANOG and breast carcinoma.